课题基金 / 基金详情

Inflammation in Covid-19: Exploration of Critical Aspects of Pathogenesis (ICECAP)

Inflammation in Covid-19: Exploration of Critical Aspects of Pathogenesis (ICECAP)
Covid-19 中的炎症:发病机制关键方面的探索 (ICECAP)
批准号:
MR/V028790/1
负责人:
Christopher Lucas
金额:
$50.58万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

Christopher Lucas的其他基金

相似基金

相关文献

中文摘要
翻译
目前的冠状病毒大流行正在造成严重的疾病和死亡。2019年严重冠状病毒病(Covid-19)可导致急性肺损伤和器官损伤,通常需要重症监护住院并长时间使用呼吸机。由于这是一种新疾病,病毒引起器官损伤的方式尚不清楚。因此,迫切和至关重要的是,必须描述严重Covid-19的影响,以便迅速为临床管理提供信息并确定新的治疗方法。ICECAP联盟是为应对Covid-19大流行而建立的。通过组建一个由临床医生和科学家组成的专家团队,我们正在研究致命的Covid-19的主要特征。授权的医院尸检为死于Covid-19的人提供了一个独特的机会,可以详细研究整个身体,这在生前是不可能的。通过收集和分析在尸检过程中收集的组织样本,这将获得关于冠状病毒在人体多个器官中存在的关键信息,并更深入地了解人体免疫系统的反应。这使我们能够快速回答重要的临床问题,并帮助快速为Covid-19治疗干预措施的评估和开发提供信息。
英文摘要
The current coronavirus pandemic is causing significant illness and death. Severe coronavirus disease 2019 (Covid-19) leads to acute lung damage and organ injury, often requiring intensive care admission and prolonged periods of time on a ventilator. As this disease is new, the way that the virus causes organ injury is not understood. It is therefore urgent and vital that the effects of severe Covid-19 are described to rapidly inform clinical management and identify new treatment approaches.The ICECAP consortium was established as a rapid response to the Covid-19 pandemic. By assembling a team of expert clinicians and scientists we are studying key features of fatal Covid-19. Authorised hospital post-mortem examinations of those who have died from Covid-19 provides a unique opportunity to study the whole body in a level of detail that is not possible during life. By collecting and analysing tissue samples collected during post-mortem examinations this will yield crucial information on the presence of the coronavirus in multiple organs in the body and also understand in greater depth how the body's immune system is responding. This allows us to rapidly answer important clinical questions and help to rapidly inform the evaluation and development of therapeutic interventions for Covid-19.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s10753-021-01567-z
发表时间: 2022-04
期刊: Inflammation
影响因子: 5.1
作者: [McAllister MJ, Kirkwood K, Chuah SC, Thompson EJ, Cartwright JA, Russell CD, Dorward DA, Lucas CD, Ho GT]
通讯作者: Ho GT
DOI: 10.1164/rccm.202008-3265oc
发表时间: 2021-01-15
期刊: American journal of respiratory and critical care medicine
影响因子: 24.7
作者: [Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, Millar T, Lerpiniere CEB, Tagliavini G, Hartley CS, Randle NP, Gachanja NN, Potey PMD, Dong X, Anderson AM, Campbell VL, Duguid AJ, Al Qsous W, BouHaidar R, Baillie JK, Dhaliwal K, Wallace WA, Bellamy COC, Prost S, Smith C, Hiscox JA, Harrison DJ, Lucas CD]
通讯作者: Lucas CD
DOI: 10.1007/s00134-021-06509-9
发表时间: 2021-11
期刊: Intensive care medicine
影响因子: 38.9
作者: [Velu PP, Lucas CD, Conway Morris A]
通讯作者: Conway Morris A
Mechanisms and Stages of Covid-19 Immunopathology Revealed by Tissue-Specific Proteomes
组织特异性蛋白质组揭示 Covid-19 免疫病理学的机制和阶段
DOI: 10.2139/ssrn.3854606
发表时间: 2021
期刊: SSRN Electronic Journal
影响因子: --
作者: [Russell C]
通讯作者: Russell C
XMaS: The National Material Science Beamline Research Facility at the ESRF
  • 批准号:
    EP/Y031164/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $475.99万
  • 财政年份:
    2024
  • 负责人:
    Christopher Lucas
  • 依托单位:
Dissecting macrophage regulation of lung epithelial regeneration
  • 批准号:
    MR/X019314/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $238.26万
  • 财政年份:
    2023
  • 负责人:
    Christopher Lucas
  • 依托单位:
XMaS Capital Equipment Upgrade
  • 批准号:
    EP/X035131/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $55.39万
  • 财政年份:
    2023
  • 负责人:
    Christopher Lucas
  • 依托单位:
Computational Methods for Speech Analysis
  • 批准号:
    2120087
  • 项目类别:
    Standard Grant
  • 资助金额:
    $24.93万
  • 财政年份:
    2021
  • 负责人:
    Christopher Lucas
  • 依托单位:
国内基金
海外基金
SPP1+巨噬细胞诱导肺CD8T细胞耗竭促进COVID-19肺修复的机制研究
  • 批准号:
    82500017
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    张慧
  • 依托单位:
CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
  • 批准号:
    82370569
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    李啸峰
  • 依托单位:
COVID-19疫情对我国儿童生长发育影响的异质性研究
  • 批准号:
    42371429
  • 项目类别:
    面上项目
  • 资助金额:
    52.00万元
  • 批准年份:
    2023
  • 负责人:
    张知新
  • 依托单位:
传染病模型的稳态切换过程研究及其在治疗COVID-19中的应用
  • 批准号:
    LQ23A010016
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    罗敏
  • 依托单位: